Basit öğe kaydını göster

dc.contributor.authorSayit, Asli Tanrivermis
dc.contributor.authorTerzi, Yuksel
dc.date.accessioned2020-06-21T13:34:00Z
dc.date.available2020-06-21T13:34:00Z
dc.date.issued2016
dc.identifier.issn1309-0720
dc.identifier.issn1309-2014
dc.identifier.urihttps://doi.org/10.4328/JCAM.2703
dc.identifier.urihttps://hdl.handle.net/20.500.12712/13443
dc.descriptionWOS: 000376566600012en_US
dc.description.abstractAim: Nasal polyps (NPs) are the most common reason for nasal obstruction, with a prevalence of 1-4%. Although the etiology is not clearly known, chronic infections and mechanical, immunological, and biochemical factors can play a role in the etiology. Recently, mean platelet volume (MPV) was recognized as a simple inflammatory marker in the inflammatory disease. In this study, we aimed to evaluate platelet (PLT) and MPV in patients with NPs. Material and Method: This study included 80 histopathologically proven patients with NPs and 80 age-and sex-matched healthy subjects as controls. The Lund-Mackay staging system was used to evalute paranasal sinus CT scans, in patients with NPs, and paranasal sinus CT scores were recorded. Values of MPV, platelet (PLT), platelet crit (PCT) and platelet distribution width (PDW) were assessed in NP and control groups. Results: MPV and PLT values were found to be low in patients with NPs, at 8.57 +/- 1.62 fL and 259.99 +/- 62.03 x103/mu L, respectively, compared with the control groups, at 8.79 +/- 1.49fL and 270.29 +/- 61.82 x103/mu L. These findings were not statistically significant. PDW values were found to be slightly high in patients with NPs, at 17.1 +/- 1.36 fL, compared with the control group, at 16.78 +/- 1.04 fL (p= 0.075). But PCT values were found to be low in patients with NPs, at 0.21 +/- 0.065, compared with the control group, at 0.23 +/- 0.069 (p= 0.044). This finding was statistically significant. Discussion: In our study, the MPV and PLT values were lower in patients with NPs, but the difference was not statistically significant. According to our findings, the use of MPV as an inflammation marker in patients with NPs does not seem to be reliable.en_US
dc.language.isoengen_US
dc.publisherDerman Medical Publen_US
dc.relation.isversionof10.4328/JCAM.2703en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectComputed Tomographyen_US
dc.subjectMean Platelet Volumeen_US
dc.subjectNasal Polypen_US
dc.subjectPlateleten_US
dc.subjectPlatelet Distribution Widthen_US
dc.titlePlatelet Count and Mean Platelet Volume in Patients with Nasal Polyposisen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume7en_US
dc.identifier.issue2en_US
dc.identifier.startpage193en_US
dc.identifier.endpage196en_US
dc.relation.journalJournal of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster